|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7010 EUR | +2.49% |
|
-17.24% | +326.06% |
| 16/07 | Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies | MT |
| 16/07 | Valerio Therapeutics, Abivax Sign R&D Deal for Inflammatory Diseases' Drug Candidates | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.36% | +2.51% | -4.69% | +20.79% | +9.58% | +83.76% | +159.34% | +340.79% | +1,343.16% | 1,062B | |
| -0.18% | +0.09% | -3.99% | +15.31% | +23.98% | +49.59% | +48.23% | +47.71% | +107.51% | 619B | |
| +0.11% | -2.63% | -4.05% | +20.53% | +6.93% | +22.87% | +62.53% | +114.21% | +268.30% | 431B | |
| +1.18% | +4.38% | +8.72% | +15.96% | +12.46% | +48.17% | +39.36% | +1.86% | +49.31% | 358B | |
| +1.25% | -0.55% | -0.71% | +11.12% | +14.87% | +35.30% | +40.12% | +48.73% | +55.72% | 293B | |
| +0.13% | -6.14% | -17.46% | -10.95% | -14.02% | +8.27% | +8.91% | +44.67% | +128.44% | 247B | |
| +0.27% | +5.26% | +10.14% | +23.20% | +23.87% | +42.40% | +60.29% | +77.90% | +135.25% | 219B | |
| +3.92% | -0.46% | -6.83% | +3.25% | -6.20% | -1.21% | -44.09% | -4.18% | +91.89% | 200B | |
| +2.14% | +2.38% | -2.24% | -0.56% | +8.61% | +20.88% | +65.25% | +94.73% | +67.18% | 162B | |
| +0.74% | +5.62% | +9.74% | -0.25% | +6.08% | +9.02% | -25.97% | -42.55% | -24.38% | 149B | |
| +0.38% | -1.58% | +10.88% | +14.28% | +19.17% | +41.71% | +6.30% | -4.60% | +6.60% | 131B | |
| +1.25% | +2.52% | -6.34% | +15.09% | +7.89% | +30.21% | +41.64% | +144.07% | +377.33% | 123B | |
| +1.06% | +1.31% | -2.31% | +5.29% | +7.25% | +41.49% | +44.71% | +8.08% | -6.71% | 104B | |
| +1.35% | +1.13% | -0.62% | +2.13% | -8.96% | -6.84% | -20.11% | -13.49% | +4.24% | 103B | |
| +1.37% | -3.03% | -9.07% | -16.83% | -16.81% | -7.50% | +66.55% | +71.38% | +480.28% | 70.25B | |
| +0.83% | +3.75% | -1.91% | +33.18% | +34.69% | +96.49% | -4.81% | +5.60% | -48.07% | 55.93B | |
| +2.12% | -3.11% | +0.42% | +5.75% | +14.58% | +30.69% | +27.53% | +52.70% | +19.68% | 54.68B | |
| +4.82% | -0.05% | -3.79% | +1.85% | -8.31% | -11.30% | +32.99% | -0.33% | +235.78% | 50.96B | |
| -0.55% | +1.68% | +1.09% | +10.24% | -1.44% | +4.65% | +14.40% | - | - | 43.92B | |
| Average | +1.10% | -0.90% | -1.21% | +8.91% | +7.06% | +28.35% | +32.80% | +54.85% | +182.86% | 235.69B | |
| Weighted average by Cap. | +0.34% | -0.62% | -2.05% | +13.02% | +9.84% | +42.86% | +62.98% | +116.55% | +410.74% |
- Stock Market
- Stocks
- ALVIO Stock
- C4X Stock
- Sector Valerio Therapeutics
Select your edition
All financial news and data tailored to specific country editions
